KORONIS PHARMACEUTICALS
Koronis Pharmaceuticals develops antiviral therapeutics based on a viral decay acceleration mechanism. It is a privately held biotechnology company developing antiviral therapeutics based on a novel mechanism, Viral Decay Accelerationâ„¢ (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV). The Company also has products in development for the treatment of hepatitis C and RSV. It was founded in 1998 and is based in Seattle, Washington.
KORONIS PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
1998-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.koronispharma.com
Total Employee:
1+
Status:
Closed
Contact:
206-682-1181
Email Addresses:
[email protected]
Total Funding:
21.06 M USD
Technology used in webpage:
SPF Google Google Cloud Google Cloud Netherlands
Current Employees Featured
Founder
Investors List
Pacific Horizon Ventures
Pacific Horizon Ventures investment in Series D - Koronis Pharmaceuticals
Asset Management Ventures (AMV)
Asset Management Ventures (AMV) investment in Series D - Koronis Pharmaceuticals
Official Site Inspections
http://www.koronispharma.com
- Host name: 162.255.119.247
- IP address: 162.255.119.247
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
